PubMed Health⌕ Search

PubMed · 3737260

A preventive context for enuresis.

Abstract

Prevention of enuresis has not been studied directly. Positive results from a randomized clinical trial evaluating early intervention for children at risk for enuresis would establish the value of prevention and help to promote its practice. Enuresis is not a disease process, and therefore a clinical trial may never be conducted, but the treatment of enuresis can be a threat to the child's health, as can the parental, professional, and peer response to the wetting. Children cannot die from wetting the bed. They can die from the medicine given to them to stop the bed wetting. Wet beds cannot cause contusions, abrasions, and concussions. Punishments administered for bed wetting can. Urine cannot cause emotional disturbance. Ridiculing, admonishing, or singling out a child for urinating can. Numerous suggestions are available to help to prevent the problems linked to enuresis, and perhaps to prevent enuresis itself. They range from the simple (e.g., waiting for the problem to resolve itself) to the very complex (e.g., promoting a change in the DSM-III criteria). The preventive suggestions in this paper are by no means exhaustive. Rather, they are an example of suggestions that can come from the literature on each aspect of enuresis: diagnosis, incidence, etiology, and treatment. A review of this literature reveals that, no matter which aspect of enuresis a researcher investigated or which body of findings a clinician examined, increased prevention could be the outcome. Child health should be the provider's abiding concern when choosing a treatment for enuresis. Management by parents and health care providers constitutes the primary threat that enuresis poses to emotional and physical health. Historically, the choice of treatment was governed more by the possibility of continence than by possible side effects on child health. The decision to use a treatment should be guided by the pediatrician's assessment of the child's readiness, willingness of the child and parents, and family resources. Although treatment is evolving, some interventions are highly rigorous and appear to focus primarily on dryness (e.g., the original dry-bed training). Treatment for enuresis has not yet been conceptualized into an encompassing context of health as have other medical maneuvers (e.g., physical examinations are now part of health maintenance). Enuresis is a presenting complaint that is not of itself a threat to health. Prevention, therefore, is its most appropriate context, and the pediatrician is the primary promoter of that context.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

P C Friman. 1986. A preventive context for enuresis.. https://doi.org/10.1016/s0031-3955(16)36078-3

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

Prevalence and risk factors for persistent faecal carriage of extended spectrum beta-lactamase producing Escherichia coli in a paediatric community population.

OBJECTIVE: To investigate clinical and microbiological factors associated with persistent faecal carriage of extended spectrum beta-lactamase (ESBL) producing Escherichia coli in infants. METHODS: Between 2010 and 2022, children aged 3 months to 2 years old were sampled in a community setting in France, at two visits, V1 and V2, 3-24 months apart, to screen for prolonged faecal carriage of ESBL-producing E. coli. Patient clinical information and whole genome sequence of each isolate were used for association studies. RESULTS: A total of 4641 children were sampled. 375 (8%) carried an ESBL-producing Enterobacterales, among which 142 of ESBL-producing E. coli carriers were once again sampled at V2 and included in this study. 21.8% (n = 31/142) and 18.4% (n = 16/99) carried the same ESBL-producing E. coli clone for at least 3 and 6 months, respectively. B2 phylogroup, and among which ST131 clones were associated with an increased risk of persistent carriage. Multivariate analysis identified virulence associated genes involved in adhesion (papC/papGII allele and a tia-like gene) and encoding toxin (senB) as major risk factors for persistence. A genome wide association study highlighted the potential role of the frz metabolic operon, known to be involved in enterocytes adhesion/internalisation. CONCLUSION: Main extraintestinal pathogenic E. coli genomic features (phylogenetic background, adhesion properties) are associated with ESBL-producing E. coli gut colonisation persistence in infants, which could potentially lead to an increased risk of febrile urinary tract infection in these patients.

Child↗

Extensive and differential platinum chemotherapy mutagenesis in livers of children.

Childhood cancer survivors often experience late adverse effects that may be linked to chemotherapy mutagenesis. We studied chemotherapy mutagenesis in normal pediatric tissues using duplex sequencing (NanoSeq) to enable the detection of mutations from single DNA molecules. We found that platinum chemotherapeutics increased the mutation burdens of normal pediatric tissues to levels seen in adults. In the liver, platinum agents imparted a tissue-specific mutational signature that was absent from other tissues. Gene-focused duplex sequencing revealed that chemotherapy mutagenesis generates a great diversity of nonsynonymous variants, some of which may have functional potential, such as leukemogenic variants in blood. Our findings demonstrate extensive chemotherapy mutagenesis in normal tissues of children, which may provide a plausible link between chemotherapy exposure and adverse effects in later life.

Child↗

Clinical and immunological characterization of a child with a homozygous TBK1 kinase-domain truncation.

TBK1 is a serine-tyrosine kinase protein that transmits signals from pattern recognition receptors to the NF-κB pathway leading to production of Type 1 Interferons. Mutations in this protein have been associated with arthritis, vasculitis, herpes simplex encephalitis and amyotrophic lateral sclerosis. In the current study, we characterized the functional consequences of a TBK1-variant bearing a truncation in exon 4 and 5 in a patient with poly arthritis resembling juvenile idiopathic arthritis and necrotizing encephalitis. The truncation was associated with reduced TBK1 protein abundance and altered phosphorylation. The variant was associated with increased basal/and or Poly-I: C induced IL-6, TNFα, IL-1β and IL-18 and type 1 Interferon ex vivo. Our findings expand the phenotypic spectrum of TBK1 loss-of-function variants and may provide insight into the management of immune dysregulation in affected patients.

Child↗